Volume 81, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Great advances have been made in developing rapid diagnostic tests (RDTs) for diagnosing malaria. To date, RDTs present an exceedingly practical format for malaria diagnosis that outperforms traditional microscopy and more experimental next generation devices in the development pipeline. However, although use of such tests is accepted in principle, their actual use has lagged. Furthermore, study of how these tests perform, what their limitations are, and how to work with these limitations to still use them effectively has stagnated. We propose that the study and implementation of such RDTs should be aggressively advanced and propose a series of questions that can guide efforts.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Perkins MD, Bell DR, 2008. Working without a blindfold: the critical role of diagnostics in malaria control. Malar J 7 (Suppl 1): S5. [Google Scholar]
  2. Zikusooka CM, McIntyre D, Barnes KI, 2008. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? Malar J 7: 176. [Google Scholar]
  3. Lubell Y, Hopkins H, Whitty CJ, Staedke SG, Mills A, 2008. An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria. Malar J 7: 21. [Google Scholar]
  4. Rolland E, Checchi F, Pinoges L, Balkan S, Guthmann JP, Guerin PJ, 2006. Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health 11: 398–408. [Google Scholar]
  5. Willcox ML, Sanogo F, Graz B, Forster M, Dakouo F, Sidibe O, Falquet J, Giani S, Diakite C, Diallo D, 2009. Rapid diagnostic tests for the home-based management of malaria, in a high-transmission area. Ann Trop Med Parasitol 103: 3–16. [Google Scholar]
  6. Bell D, Perkins MD, 2008. Making malaria testing relevant: beyond test purchase. Trans R Soc Trop Med Hyg 102: 1064–1066. [Google Scholar]
  7. Peeling RW, Smith PG, Bossuyt PM, 2006. A guide for diagnostic evaluations. Nat Rev Microbiol 4 (Suppl): S2–S6. [Google Scholar]
  8. Bell D, Wongsrichanalai C, Barnwell JW, 2006. Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol 4: 682–695. [Google Scholar]
  9. Urdea M, Penny LA, Olmsted SS, Giovanni MY, Kaspar P, Shepherd A, Wilson P, Dahl CA, Buchsbaum S, Moeller G, Hay Burgess DC, 2006. Requirements for high impact diagnostics in the developing world. Nature 444 (Suppl 1): 73–79. [Google Scholar]
  10. Shiff CJ, Premji Z, Minjas JN, 1993. The rapid manual ParaSight-F test. A new diagnostic tool for Plasmodium falciparum infection. Trans R Soc Trop Med Hyg 87: 646–648. [Google Scholar]
  11. Beadle C, Long GW, Weiss WR, McElroy PD, Maret SM, Oloo AJ, Hoffman SL, 1994. Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay. Lancet 343: 564–568. [Google Scholar]
  12. Sullivan DJ Jr, Gluzman IY, Goldberg DE, 1996. Plasmodium hemozoin formation mediated by histidine-rich proteins. Science 271: 219–222. [Google Scholar]
  13. Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, Pitisuttithum P, Smithyman AM, Day NP, White NJ, 2005. Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg 99: 517–524. [Google Scholar]
  14. Zerpa NC, Wide A, Noda J, Bermudez H, Pabon R, Noya OO, 2006. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins. Exp Parasitol 113: 227–234. [Google Scholar]
  15. Mariette N, Barnadas C, Bouchier C, Tichit M, Menard D, 2008. Country-wide assessment of the genetic polymorphism in Plasmodium falciparum and Plasmodium vivax antigens detected with rapid diagnostic tests for malaria. Malar J 7: 219. [Google Scholar]
  16. Baker J, McCarthy J, Gatton M, Kyle DE, Belizario V, Luchavez J, Bell D, Cheng Q, 2005. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis 192: 870–877. [Google Scholar]
  17. Lee N, Baker J, Andrews KT, Gatton ML, Bell D, Cheng Q, McCarthy J, 2006. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific mono-clonal antibodies: Implications for rapid diagnostic tests for malaria. J Clin Microbiol 44: 2773–2778. [Google Scholar]
  18. Piper R, Lebras J, Wentworth L, Hunt-Cooke A, Houze S, Chiodini P, Makler M, 1999. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am J Trop Med Hyg 60: 109–118. [Google Scholar]
  19. Oduola AM, Omitowoju GO, Sowunmi A, Makler MT, Falade CO, Kyle DE, Fehintola FA, Ogundahunsi OA, Piper RC, Schuster BG, Milhous WK, 1997. Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria. Exp Parasitol 87: 283–289. [Google Scholar]
  20. Makler MT, Hinrichs DJ, 1993. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg 48: 205–210. [Google Scholar]
  21. Cooke AH, Chiodini PL, Doherty T, Moody AH, Ries J, Pinder M, 1999. Comparison of a parasite lactate dehydrogenase-based immunochromatographic antigen detection assay (OptiMAL) with microscopy for the detection of malaria parasites in human blood samples. Am J Trop Med Hyg 60: 173–176. [Google Scholar]
  22. Talman AM, Duval L, Legrand E, Hubert V, Yen S, Bell D, Le Bras J, Ariey F, Houze S, 2007. Evaluation of the intra- and inter-specific genetic variability of Plasmodium lactate dehydrogenase. Malar J 6: 140. [Google Scholar]
  23. Murray CK, Gasser RA Jr, Magill AJ, Miller RS, 2008. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev 21: 97–110. [Google Scholar]
  24. Mueller I, Betuela I, Ginny M, Reeder JC, Genton B, 2007. The sensitivity of the OptiMAL rapid diagnostic test to the presence of Plasmodium falciparum gametocytes compromises its ability to monitor treatment outcomes in an area of Papua New Guinea in which malaria is endemic. J Clin Microbiol 45: 627–630. [Google Scholar]
  25. Tjitra E, Anstey NM, 2001. Will the high rates of post-treatment sexual stage parasitaemia seen in malaria-endemic areas make the optiMAL antigen test unreliable in predicting malaria treatment outcome? Br J Haematol 113: 255–257. [Google Scholar]
  26. Miller RS, McDaniel P, Wongsrichanalai C, 2001. Following the course of malaria treatment by detecting parasite lactate dehydrogenase enzyme. Br J Haematol 113: 558–559. [Google Scholar]
  27. Sowunmi A, Balogun ST, Gbotosho GO, Happi CT, 2008. Plasmodium falciparum gametocyte sex ratios in children with acute, symptomatic, uncomplicated infections treated with amodiaquine. Malar J 7: 169. [Google Scholar]
  28. Sowunmi A, Fateye BA, 2003. Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Trop Med Int Health 8: 783–792. [Google Scholar]
  29. Sowunmi A, Balogun ST, Gbotosho GO, Happi CT, 2009. Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs. Acta Trop 109: 108–117. [Google Scholar]
  30. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347: 1654–1658. [Google Scholar]
  31. Barnes KI, White NJ, 2005. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop 94: 230–240. [Google Scholar]
  32. von Seidlein L, Drakeley C, Greenwood B, Walraven G, Targett G, 2001. Risk factors for gametocyte carriage in Gambian children. Am J Trop Med Hyg 65: 523–527. [Google Scholar]
  33. Hopkins H, Kambale W, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ, 2007. Comparison of HRP2- and pLDH-based rapid diagnostic tests for malaria with longitudinal follow-up in Kampala, Uganda. Am J Trop Med Hyg 76: 1092–1097. [Google Scholar]
  34. Ochola LB, Marsh K, Lowe B, Gal S, Pluschke G, Smith T, 2005. Estimation of the sequestered parasite load in severe malaria patients using both host and parasite markers. Parasitology 131: 449–458. [Google Scholar]
  35. Tarimo DS, Minjas JN, Bygbjerg IC, 2001. Malaria diagnosis and treatment under the strategy of the integrated management of childhood illness (IMCI): relevance of laboratory support from the rapid immunochromatographic tests of ICT Malaria P.f/P.v and OptiMal. Ann Trop Med Parasitol 95: 437–444. [Google Scholar]
  36. Iqbal J, Siddique A, Jameel M, Hira PR, 2004. Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection. J Clin Microbiol 42: 4237–4241. [Google Scholar]
  37. Wu YS, Li M, Lu JH, Bi HX, Li YJ, 2002. Plasmodium lactate dehydrogenase activity assay and its preliminary application in therapeutic efficacy monitoring of drugs [in Chinese]. Di Yi Jun Yi Da Xue Xue Bao 22: 25–27. [Google Scholar]
  38. Grobusch MP, Hanscheid T, Gobels K, Slevogt H, Zoller T, Rogler G, Teichmann D, 2003. Comparison of three antigen detection tests for diagnosis and follow-up of falciparum malaria in travellers returning to Berlin, Germany. Parasitol Res 89: 354–357. [Google Scholar]
  39. Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ, 2008. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. J Infect Dis 197: 1605–1613. [Google Scholar]
  40. Mendez F, Munoz A, Carrasquilla G, Jurado D, Arevalo-Herrera M, Cortese JF, Plowe CV, 2002. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol 156: 230–238. [Google Scholar]
  41. Sowunmi A, Fateye BA, Adedeji AA, Fehintola FA, Happi TC, 2004. Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children. Parasitology 129: 255–262. [Google Scholar]
  42. McKenzie FE, Wongsrichanalai C, Magill AJ, Forney JR, Permpanich B, Lucas C, Erhart LM, O’Meara WP, Smith DL, Sirichaisinthop J, Gasser RA Jr, 2006. Gametocytemia in Plasmodium vivax and Plasmodium falciparum infections. J Parasitol 92: 1281–1285. [Google Scholar]
  43. Kilian AH, Metzger WG, Mutschelknauss EJ, Kabagambe G, Langi P, Korte R, von Sonnenburg F, 2000. Reliability of malaria microscopy in epidemiological studies: results of quality control. Trop Med Int Health 5: 3–8. [Google Scholar]
  44. Martin SK, Rajasekariah GH, Awinda G, Waitumbi J, Kifude C, 2009. Unified parasite lactate dehydrogenase and histidine-rich protein ELISA for quantification of Plasmodium falciparum. Am J Trop Med Hyg 80: 516–522. [Google Scholar]
  45. O’Meara WP, Barcus M, Wongsrichanalai C, Muth S, Maguire JD, Jordan RG, Prescott WR, McKenzie FE, 2006. Reader technique as a source of variability in determining malaria parasite density by microscopy. Malar J 5: 118. [Google Scholar]
  46. O’Meara WP, McKenzie FE, Magill AJ, Forney JR, Permpanich B, Lucas C, Gasser RA Jr, Wongsrichanalai C, 2005. Sources of variability in determining malaria parasite density by microscopy. Am J Trop Med Hyg 73: 593–598. [Google Scholar]
  47. Bejon P, Andrews L, Hunt-Cooke A, Sanderson F, Gilbert SC, Hill AV, 2006. Thick blood film examination for Plasmodium falciparum malaria has reduced sensitivity and underestimates parasite density. Malar J 5: 104. [Google Scholar]
  48. Lon CT, Alcantara S, Luchavez J, Tsuyuoka R, Bell D, 2005. Positive control wells: a potential answer to remote-area quality assurance of malaria rapid diagnostic tests. Trans R Soc Trop Med Hyg 99: 493–498. [Google Scholar]
  49. Chiodini PL, Bowers K, Jorgensen P, Barnwell JW, Grady KK, Luchavez J, Moody AH, Cenizal A, Bell D, 2007. The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Trans R Soc Trop Med Hyg 101: 331–337. [Google Scholar]
  50. Rakotonirina H, Barnadas C, Raherijafy R, Andrianantenaina H, Ratsimbasoa A, Randrianasolo L, Jahevitra M, Andriantsoanirina V, Menard D, 2008. Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries. Am J Trop Med Hyg 78: 217–221. [Google Scholar]
  51. Bharti PK, Silawat N, Singh PP, Singh MP, Shukla M, Chand G, Dash AP, Singh N, 2008. The usefulness of a new rapid diagnostic test, the First Response Malaria Combo (pLDH/HRP2) card test, for malaria diagnosis in the forested belt of central India. Malar J 7: 126. [Google Scholar]
  52. Drakeley C, Reyburn H, 2009. Out with the old, in with the new: the utility of rapid diagnostic tests for malaria diagnosis in Africa. Trans R Soc Trop Med Hyg 103: 333–337. [Google Scholar]
  53. Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dorsey G, 2008. Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda. J Infect Dis 197: 510–518. [Google Scholar]
  54. Randrianasolo L, Tafangy PB, Raharimalala LA, Ratsimbasoa AC, Randriamanantena A, Randrianarivelojosia M, 2007. Rapid diagnostic test for malaria: preliminary study in Madagascar in 2003 [in French]. Sante 17: 69–73. [Google Scholar]
  55. Fogg C, Twesigye R, Batwala V, Piola P, Nabasumba C, Kiguli J, Mutebi F, Hook C, Guillerm M, Moody A, Guthmann JP, 2008. Assessment of three new parasite lactate dehydrogenase (pan-pLDH) tests for diagnosis of uncomplicated malaria. Trans R Soc Trop Med Hyg 102: 25–31. [Google Scholar]
  56. Ratsimbasoa A, Fanazava L, Radrianjafy R, Ramilijaona J, Rafanomezantsoa H, Menard D, 2008. Evaluation of two new immunochromatographic assays for diagnosis of malaria. Am J Trop Med Hyg 79: 670–672. [Google Scholar]
  57. Ratsimbasoa A, Randriamanantena A, Raherinjafy R, Rasoarilalao N, Menard D, 2007. Which malaria rapid test for Madagascar? Field and laboratory evaluation of three tests and expert microscopy of samples from suspected malaria patients in Madagascar. Am J Trop Med Hyg 76: 481–485. [Google Scholar]
  58. Moody AH, Chiodini PL, 2002. Non-microscopic method for malaria diagnosis using OptiMAL IT, a second-generation dip-stick for malaria pLDH antigen detection. Br J Biomed Sci 59: 228–231. [Google Scholar]
  59. Bertinchant JP, Robert E, Polge A, Marty-Double C, Fabbro-Peray P, Poirey S, Aya G, Juan JM, Ledermann B, de la Coussaye JE, Dauzat M, 2000. Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats. Clin Chim Acta 298: 13–28. [Google Scholar]
  60. de Oliveira AM, Skarbinski J, Ouma PO, Kariuki S, Barnwell JW, Otieno K, Onyona P, Causer LM, Laserson KF, Akhwale WS, Slutsker L, Hamel M, 2009. Performance of malaria rapid diagnostic tests as part of routine malaria case management in Kenya. Am J Trop Med Hyg 80: 470–474. [Google Scholar]
  61. Abeku TA, Kristan M, Jones C, Beard J, Mueller DH, Okia M, Rapuoda B, Greenwood B, Cox J, 2008. Determinants of the accuracy of rapid diagnostic tests in malaria case management: evidence from low and moderate transmission settings in the East African highlands. Malar J 7: 202. [Google Scholar]
  62. Chanda P, Castillo-Riquelme M, Masiye F, 2009. Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia. Cost Eff Resour Alloc 7: 5. [Google Scholar]
  63. Elmardi KA, Malik EM, Abdelgadir T, Ali SH, Elsyed AH, Mudather MA, Elhassan AH, Adam I, 2009. Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan’s conditions using artemisinin-based combination therapy and rapid diagnostic test. Malar J 8: 39. [Google Scholar]
  64. Bisoffi Z, Sirima BS, Angheben A, Lodesani C, Gobbi F, Tinto H, Van den Ende J, 2009. Rapid malaria diagnostic tests vs. clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial. Trop Med Int Health 14: 491–498. [Google Scholar]
  65. Valea I, Tinto H, Nikiema M, Yamuah L, Rouamba N, Drabo M, Guiguemde RT, d’Alessandro U, 2009. Performance of OptiMAL-IT compared to microscopy, for malaria detection in Burkina Faso. Trop Med Int Health 14: 338–340. [Google Scholar]
  66. English M, Reyburn H, Goodman C, Snow RW, 2009. Abandoning presumptive antimalarial treatment for febrile children aged less than five years–a case of running before we can walk? PLoS Med 6: e1000015. [Google Scholar]
  67. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty CJ, Mills A, 2008. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ 86: 101–110. [Google Scholar]
  68. Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda P, Sipilinyambe N, Simon JL, Snow RW, 2007. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA 297: 2227–2231. [Google Scholar]
  • Received : 20 Apr 2009
  • Accepted : 27 Aug 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error